PetMed Express (PETS) Set to Announce Earnings on Wednesday

PetMed Express (NASDAQ:PETS) will issue its quarterly earnings data after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.30. PetMed Express had a negative return on equity of 3.44% and a negative net margin of 1.24%. The business had revenue of $67.95 million during the quarter, compared to analysts’ expectations of $77.52 million. On average, analysts expect PetMed Express to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

PetMed Express Trading Down 2.6 %

Shares of PETS traded down $0.11 during midday trading on Tuesday, hitting $4.11. The company’s stock had a trading volume of 70,177 shares, compared to its average volume of 331,363. PetMed Express has a one year low of $2.90 and a one year high of $8.27. The company’s fifty day simple moving average is $3.71 and its two-hundred day simple moving average is $3.87.

Insider Activity

In related news, major shareholder Nina Capital Holdings Inc. bought 12,500 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were bought at an average price of $3.34 per share, for a total transaction of $41,750.00. Following the completion of the acquisition, the insider now owns 2,078,000 shares of the company’s stock, valued at $6,940,520. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

Separately, Lake Street Capital reaffirmed a “hold” rating and set a $3.50 price objective (down previously from $7.00) on shares of PetMed Express in a research report on Wednesday, August 7th.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.